Reactive Glia not only Associates with Plaques but also Parallels Tangles in Alzheimer’s Disease

Serrano-Pozo, Alberto, Mielke, Matthew L., Gómez-Isla, Teresa, Betensky, Rebecca A., Growdon, John H., Frosch, Matthew P., Hyman, Bradley T.·2011·The American Journal of Pathology

Cited by (487)

Items 301–400 of 487

  1. Amyloid β peptide-mediated neurotoxicity is attenuated by the proliferating microglia more potently than by the quiescent phenotype
    Huey-Jen Tsay, Yung‐Cheng Huang, Fong-Lee Huang, Chia-Ping Chen, Yu-Chun Tsai, Ying-Hsiu Wang, Mine-Fong Wu, Feng-Yi Chiang, Young‐Ji Shiao · 2013 · Journal of Biomedical Science
  2. Co-expression network analysis of human tau-transgenic mice reveals protein modules associated with tau-induced pathologies
    Tsumagari, Kazuya, Sato, Yoshiaki, Shimozawa, Aki, Aoyagi, Hirofumi, Okano, Hideyuki, Kuromitsu, Junro · 2022 · iScience
  3. The role of signaling crosstalk of microglia in hippocampus on progression of ageing and Alzheimer's disease
    He Li, Tianyuan Ye, Xingyang Liu, Rui Guo, Xiuzhao Yang, Yangyi Li, Dongmei Qi, Yihua Wei, Yifan Zhu, Lei Wen et al. · 2023 · Journal of Pharmaceutical Analysis
  4. Metformin Prevents NDEA-Induced Memory Impairments Associated with Attenuating Beta-Amyloid, Tumor Necrosis Factor-Alpha, and Interleukin-6 Levels in the Hippocampus of Rats
    Teresa Ponce-López, José Antonio González Álvarez Tostado, Fernando Dias, Keren Happuck Montiel Maltez · 2023 · Biomolecules
  5. PET Imaging to Measure Neuroinflammation In Vivo
    Maura Malpetti, Nicolai Franzmeier, Matthias Brendel · 2024 · Methods in molecular biology
  6. Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of Alzheimer’s Disease
    Yanyan Kong, Cinzia Maschio, Xuefeng Shi, Bolin Yao, Fang Xie, Chuantao Zuo, Uwe Konietzko, Kuangyu Shi, Axel Rominger, Jianfei Xiao et al. · 2024 · Molecular Neurobiology
  7. Neuroimaging of Diseases Causing Dementia
    Joseph C. Masdeu · 2019 · Neurologic Clinics
  8. A Comprehensive Analysis Identified Hub Genes and Associated Drugs in Alzheimer’s Disease
    Qi Jing, Hui Zhang, Xiaoru Sun, Yaru Xu, Silu Cao, Yiling Fang, Xuan Zhao, Cheng Li · 2021 · BioMed Research International
  9. Erythropoietin-derived peptide treatment reduced neurological deficit and neuropathological changes in a mouse model of tauopathy
    Yun‐Beom Choi, Ambrose A. Dunn-Meynell, Michelle E. Marchese, Benjamin M. Blumberg, Deeya Gaindh, Peter C. Dowling, Wei Lü · 2021 · Alzheimer s Research & Therapy
  10. Oxygen Sensing and Signaling in Alzheimer’s Disease: A Breathtaking Story!
    Sónia C. Correia, Paula Isabel Moreira · 2021 · Cellular and Molecular Neurobiology
  11. Is the Exposome Involved in Brain Disorders through the Serotoninergic System?
    Denis Sarrouilhe, Norah Defamie, Marc Mesnil · 2021 · Biomedicines
  12. Exploring Potential of Alkaloidal Phytochemicals Targeting Neuroinflammatory Signaling of Alzheimer's Disease
    Md. Sahab Uddin, Md. Tanvir Kabir, Abdullah Al Mamun, Tapan Behl, Rasha Abdulrashed Mansouri, Akram Ahmed Aloqbi, Asma Perveen, Abdul Hafeez, Ghulam Md Ashraf · 2020 · Current Pharmaceutical Design
  13. Progression of Alzheimer’s Disease-Related Pathology and Cell Counts in a Patient with Idiopathic Normal Pressure Hydrocephalus
    Sylwia Libard, Katarina Laurell, Kristina Giuliana Cesarini, Irina I. Alafuzoff · 2018 · Journal of Alzheimer s Disease
  14. Clustering of activated microglia occurs before the formation of dystrophic neurites in the evolution of Aβ plaques in Alzheimer’s disease.
    Patrick Jarmo Paasila, Danielle Davies, Greg Trevor Sutherland, Claire S. Goldsbury · 2020 · Free Neuropathology
  15. Genetic and Functional Dynamics of Butyrylcholinesterase in Alzheimer's Disease: From Mechanisms to Clinical Relevance.
    Prešern, Uroš, Goličnik, Marko, Bavec, Aljoša · 2026 · Chemico-Biological Interactions
  16. Estimation of blood-based biomarkers of glial activation related to neuroinflammation
    Fumihiko Yasuno, Atsushi Watanabe, Yasuyuki Kimura, Yumeka Yamauchi, Aya Ogata, Hiroshi Ikenuma, Junichiro Abe, Hiroyuki Minami, Takashi Nihashi, Kastunori Yokoi et al. · 2022 · Brain Behavior & Immunity - Health
  17. The investigation of peripheral inflammatory and oxidative stress biomarkers in dementia with Lewy Bodies, compared with Alzheimer’s Disease, and mild cognitive impairment
    Yueyi Yu, Huixin Shen, Qi Qin, Jing Wang, Yuting Nie, Lulu Wen, Yi Tang, Miao Qu · 2025 · Neuroscience
  18. Cerebrovascular inflammation is associated with tau pathology in Guam parkinsonism dementia
    Petra Majerová, Ralph M. Garruto, Andrej Kováč · 2018 · Journal of Neural Transmission
  19. GART expression in rat spinal cord after injury and its role in inflammation
    Dongmei Zhang, Ying Yue, Shengyang Jiang, Aihong Li, Aisong Guo, Xinming Wu, Xiaopeng Xia, Hongbing Cheng, Jinlong Zhang, Tao Tao et al. · 2014 · Brain Research
  20. Common Pathological Mechanisms and Risk Factors for Alzheimer’s Disease and Type-2 Diabetes: Focus on Inflammation
    Emmanuel Moyse, Mohamed Haddad, Camélia Benlabiod, Charles Ramassamy, Slavica M Krantic · 2019 · Current Alzheimer Research
  21. Role of de novo lipogenesis in inflammation and insulin resistance in Alzheimer's disease
    Mohsin Ali Khan, Zaw Ali Khan, Fouzia Shoeb, Ghizal Fatima, Rizwan Hasan Khan, Mohammad M. Khan · 2023 · International Journal of Biological Macromolecules
  22. Kallikrein-related peptidase's significance in Alzheimer's disease pathogenesis: A comprehensive survey
    Rilès Boumali, Laureline Urli, Meriem Naïm, Feryel Soualmia, Kiyoka Kinugawa, Isabelle Petropoulos, Chahrazade El Amri · 2024 · Biochimie
  23. Microglial responses partially mediate the effect of Aβ on cognition in Alzheimer's disease
    Lasse Stensvig Madsen, Rola Ismail, Peter Parbo, Pernille Louise Kjeldsen, Jeppe L. Schaldemose, Kim Vang Hansen, Hanne Gottrup, Joel Aanerud, Simon Fristed Eskildsen, David James Brooks · 2024 · Alzheimer s & Dementia
  24. Neuroimaging Biomarkers in Alzheimer’s Disease
    Tapan K. Khan · 2016 · Elsevier eBooks
  25. Recent Advances in Progresses and Prospects of IL-37 in Central Nervous System Diseases
    Xinrui Li, Bing Yan, Jin Du, Shanshan Xu, Lu Liu, Caifei Pan, Xianhui Kang, Shengmei Zhu · 2022 · Brain Sciences
  26. The Pivotal Neuroinflammatory, Therapeutic and Neuroprotective Role of Alpha-Mangostin
    Seidu A. Richard, Songping Zheng, Zhaoliang Su, Jing Gao, Huaxi Xu · 2017 · Journal of Neurology Research
  27. Plasma glial fibrillary acidic protein is an early marker of amyloid pathology in Alzheimer's disease
    J. Pereira, S. Janelidze, Ruben Smith, N. Mattsson-Carlgren, S. Palmqvist, H. Zetterberg, E. Stomrud, N. Ashton, K. Blennow, O. Hansson · 2021 · medRxiv
  28. Neuroprotection beyond neurons: integrated biomarker-based and astroglia- or microglia-targeted approaches to combat neurodegenerative diseases
    Cinzia Volonté, Guoku Hu, Christopher A. Shaw, Viegas Junior Claudio, Joyce Alves dos Santos, Sandra Henriques Vaz, Ana Morais Sebastião, Vladimír J. Balcar, P. David Mozley, Federico Verde et al. · 2026 · Exploration of Neuroprotective Therapy
  29. Neuronal loss and inflammation preceding fibrillary tau pathology in a rat model with early human-like tauopathy
    Joshua T. Emmerson, Janice C. Malcolm, Sonia Do Carmo, Phuoc Nguyen, Lionel Breuillaud, Julio Martínez-Trujillo, A. Claudio Cuello · 2023 · Neurobiology of Disease
  30. Astrocytic proteins involved in regulation of the extracellular environment are increased in the Alzheimer's disease middle temporal gyrus
    Henry Liu, Adelie Y. S. Tan, Nasim F. Mehrabi, Clinton P. Turner, Maurice A. Curtis, Richard L. M. Faull, Mike Dragunow, Malvindar K. Singh‐Bains, Amy M. Smith · 2024 · Neurobiology of Disease
  31. Rare Variants and Transcriptomics in Alzheimer disease
    Crystal Humphries, Martin A. Kohli · 2014 · Current Genetic Medicine Reports
  32. Microglia in Alzheimer’s Disease: A Favorable Cellular Target to Ameliorate Alzheimer’s Pathogenesis
    Dewan Md. Sumsuzzman, Md. Sahab Uddin, Md. Tanvir Kabir, Sharifa Hasana, Asma Perveen, Ibtesam S. Alanazi, Ghadeer Mohsen Albadrani, Mohamed M. Abdel‐Daim, Ghulam Md Ashraf · 2022 · Mediators of Inflammation
  33. The relationships between neuroglial alterations and neuronal changes in Alzheimer’s disease, and the related controversies I: Gliopathogenesis and glioprotection
    Adolfo Toledano‐Díaz, María‐Isabel Álvarez, A. Tolédano · 2022 · Journal of Central Nervous System Disease
  34. Protective effects of Centella asiatica extract on spatial memory and learning deficits in animal model of systemic inflammation induced by lipopolysaccharide
    Mazura Md Pisar, Beng Jin Chee, Idris Long, Asiah Osman · 2023 · Annals of Medicine
  35. Inflammation in Alzheimer’s disease: A friend or foe?
    Samaila Musa Chiroma, Mohamad Taufik Hidayat Baharuldin, Che Norma Mat Taib, Zulkhairi Amom, Saravanan Jagadeesan, Mohamad Aris Mohd Moklas · 2018 · Biomedical Research and Therapy
  36. Pathological tau propagation from the brain to the colon via the vagal efferent pathway in Alzheimer’s disease
    Hyunjung Choi, Seok Beom Hong, Hui-Wen Liu, Hyeonggyu Song, June‐Hyun Jeong, Kyusik Ahn, Seong‐Jun Kim, Jae‐Hoon Song, Jong Won Han, Dongjoon Lee et al. · 2025 · Gut
  37. Navigating the nano-bio immune interface: advancements and challenges in CNS nanotherapeutics
    Chantalle Moulton, Anna Baroni, Erica Quagliarini, Lucia Leone, Luca Digiacomo, Marta Morotti, Giulio Caracciolo, Maria Vittoria Podda, Ennio Tasciotti · 2024 · Frontiers in Immunology
  38. Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets
    Xiaofeng Fu, Huimin Cai, Shuiyue Quan, Ziye Ren, Yuyun Xu, Longfei Jia · 2024 · Medical Review
  39. Ox-inflammasome involvement in neuroinflammation
    Andrea Vallese, Valeria Cordone, Alessandra Pecorelli, Giuseppe Valacchi · 2023 · Free Radical Biology and Medicine
  40. Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model
    Joshua T. Emmerson, Sonia Do Carmo, Yingying Liu, Ali Shalhoub, Liu Ai, Quentin Bonomo, Janice C. Malcolm, Lionel Breuillaud, A. Claudio Cuello · 2023 · Neurobiology of Disease
  41. Astrocyte–Neuron Communications
    Sally R. McIver, Mathilde Faideau, Philip G. Haydon · 2012 · Springer eBooks
  42. Multi-scale modeling for systematically understanding the key roles of microglia in AD development
    Zhiwei Ji, Changan Liu, Weiling Zhao, Claudio A. Soto, Xiaobo Zhou · 2021 · Computers in Biology and Medicine
  43. Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease
    Alberto Serrano‐Pozo, Zhaozhi Li, Maya E. Woodbury, Clara Muñoz‐Castro, Astrid Wachter, Rojashree Jayakumar, Annie G. Bryant, Ayush Noori, Lindsay A. Welikovitch, Miwei Hu et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  44. Dual-specificity protein phosphatase 6 (DUSP6) overexpression reduces amyloid load and improves memory deficits in male 5xFAD mice
    Allen L. Pan, Mickaël Audrain, Emmy Sakakibara, Rajeev Joshi, Xiaodong Zhu, Qian Wang, Minghui Wang, Noam D. Beckmann, Eric E. Schadt, Sam Gandy et al. · 2024 · Frontiers in Aging Neuroscience
  45. scMultiMap: Cell-type-specific mapping of enhancers and target genes from single-cell multimodal data
    Chang Su, Dongsoo Lee, Peng Jin, Jingfei Zhang · 2025 · Nature Communications
  46. Multitracer Approach to Understanding the Complexity of Reactive Astrogliosis in Alzheimer’s Brains
    I. Fontana, Amit Kumar, Nobuyuki Okamura, A. Nordberg · 2023 · ACS Chemical Neuroscience
  47. Multidimensional MRI reveals cortical astrogliosis linked to dementia in Alzheimer’s disease
    Stephanie Barsoum, Caitlin S. Latimer, Amber Nolan, Alexander Barrett, Koping Chang, Juan Carlos Troncoso, Christopher Dirk Keene, Dan Benjamini · 2025 · Brain Communications
  48. Postmortem Associations Between Alzheimer Disease Pathology and Plasma pTau217, GFAP, and NfL in AD and AD-Related Dementias
    Pia Kivisäkk, Hadia A. Fatima, Chao‐Yi Wu, Nikhil Padmanabhan, Daniel Romero, Taron Gorham, Molly Weik, Hiroko H. Dodge, Clemens R. Scherzer, Sudeshna Das et al. · 2026 · Neurology
  49. Neuropathologic Findings in Elderly HIV-Positive Individuals
    Shino Magaki, Harry V. Vinters, Christopher K Williams, Sergey Mareninov, Négar Khanlou, Jonathan W. Said, Natasha M. Nemanim, Jessica Gonzalez, Jose G Morales, Elyse J. Singer et al. · 2022 · Journal of Neuropathology & Experimental Neurology
  50. Astrocytic clearance and fragmentation of toxic proteins in Alzheimer’s disease on large-scale brain networks
    Hina Shaheen, Swadesh Pal, Roderick Melnik · 2023 · Physica D Nonlinear Phenomena
  51. Neuroprotective effect of tanshinone IIA-modified mesenchymal stem cells in a lipopolysaccharide-induced neuroinflammation model
    Jingjing Wu, Jian Chen, Ying Ge, Nanqu Huang, Yong Luo · 2024 · Heliyon
  52. Different Molecular Mechanisms Mediate Direct or Glia-Dependent Prion Protein Fragment 90–231 Neurotoxic Effects in Cerebellar Granule Neurons
    Stefano Thellung, Elena Gatta, Francesca Pellistri, Valentina Villa, Alessandro Corsaro, Mario Nizzari, Mauro Robello, Tullio Florio · 2017 · Neurotoxicity Research
  53. 18F-THK5351 PET Imaging in the Behavioral Variant of Frontotemporal Dementia
    Gijin Nam, Hye-Jin Jeong, Jae Myeong Kang, Sang‐Yoon Lee, Seongho Seo, Ha‐Eun Seo, Kee Hyung Park, Byeong Kil Yeon, Tatsuo Ido, Dong Jin Shin et al. · 2018 · Dementia and Neurocognitive Disorders
  54. Tau pathology mediated the plasma biomarkers and cognitive function in patients with mild cognitive impairment
    Lu Zhao, Qi Qiu, Shaowei Zhang, Feng Yan, Xia Li · 2024 · Experimental Gerontology
  55. Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer’s disease
    Artem Zatcepin, Johannes S. Gnörich, Boris‐Stephan Rauchmann, Laura M. Bartos, Stephan Wagner, Nicolai Franzmeier, Maura Malpetti, Xianyuan Xiang, Yuan Shi, Samira Parhizkar et al. · 2024 · Molecular Neurodegeneration
  56. Mild Microglial Responses in the Cortex and Perivascular Macrophage Infiltration in Subcortical White Matter in Dogs with Age-Related Dementia Modelling Prodromal Alzheimer’s Disease
    Barbara Blicher Thomsen, Cecilie Madsen, Katrine Tækker Krohn, Camilla Thygesen, Trine Schütt, Athanasios Metaxas, Sultan Darvesh, Jørgen Steen Agerholm, Martin Wirenfeldt, Mette Berendt et al. · 2021 · Journal of Alzheimer s Disease
  57. Depressive-like Behaviors Induced by mGluR5 Reduction in 6xTg in Mouse Model of Alzheimer’s Disease
    Youngkyo Kim, Jinho Kim, Shinwoo Kang, Keun‐A Chang · 2023 · International Journal of Molecular Sciences
  58. Astrocyte–Neuron Interactions in Alzheimer’s Disease
    Clara Muñoz‐Castro, Alberto Serrano‐Pozo · 2024 · Advances in neurobiology
  59. APP Knock-In Mice Produce E22P-Aβ Exhibiting an Alzheimer’s Disease-like Phenotype with Dysregulation of Hypoxia-Inducible Factor Expression
    Takahito Maki, Masahito Sawahata, Ichiro Akutsu, Shohei Amaike, Genki Hiramatsu, Daisuke Uta, Naotaka Izuo, Takahiko Shimizu, Kazuhiro Irie, Toshiaki Kume · 2022 · International Journal of Molecular Sciences
  60. The Epidemiological Neuropathology of Dementia and the Implications for Drug Development
    Blossom C. M. Stephan, Stephen B. Wharton, Julie E. Simpson, Fiona E. Matthews, Paul G. Ince, Carol Brayne · 2012 · Neurodegenerative Disease Management
  61. Amyloid Beta (Aβ) and Oxidative Stress: Progression of Alzheimer’s Disease
    Razaul Haque · 2018 · Advances in Biotechnology & Microbiology
  62. Regional brain structural alterations in reward and salience networks in asthma
    Danielle Carrol, William W. Busse, Corrina J. Frye, Danika R. Klaus, Julia C. Bach, Heather L. Floerke, Barbara B. Bendlin, Henrik Zetterberg, Kaj Blennow, Amanda Heslegrave et al. · 2025 · Brain Behavior and Immunity
  63. Phytochemicals as Substances that Affect Astrogliosis and their Implications for the Management of Neurodegenerative Diseases
    Fatemeh Forouzanfar, Ali Mohammad Pourbagher‐Shahri, Farzaneh Vafaee, Thozhukat Sathyapalan, Amirhossein Sahebkar · 2023 · Current Medicinal Chemistry
  64. Study on multi-target effects of the novel HDAC6 inhibitor W5 on Aβ/Cu2+-induced Alzheimer's disease model of rats
    Ruihua Liu, Linli Guo, Yanan Zhao, Jiasi Yu, Jiasi Yu, Ping Liu · 2024 · Brain Research
  65. Distinct inflammatory profiles in young‐onset versus late‐onset Alzheimer's disease
    Simrika Thapa, Chloe Anastassiadis, Anna Vasilevskaya, Foad Taghdiri, Igor Jurišica, Mohsen Hadian, Patrick Salwierz, Faiza Robbani, Pia Kivisäkk, Bradley T. Hyman et al. · 2025 · Alzheimer s & Dementia
  66. Salivary Glands: A Powerful Experimental System to Study Cell Biology in Live Animals by Intravital Microscopy
    Monika Šrámková, Natalie Porat‐Shliom, Andrius Masedunkas, Timothy Wigand, Panomwat Amornphimoltham, Roberto Weigert · 2012 · InTech eBooks
  67. Genetic and degenerative disorders primarily causing dementia
    Joseph C. Masdeu, Belén Pascual · 2016 · Handbook of clinical neurology
  68. Brain aging, Alzheimer's disease, and the role of stem cells in primate comparative studies
    Isabel August, Katerina Semendeferi, Maria Carolina Marchetto · 2022 · The Journal of Comparative Neurology
  69. Editorial: The Role of Glia in Alzheimer's Disease
    Beatriz Gomez Perez‐Nievas, Alberto Serrano‐Pozo · 2019 · Frontiers in Neurology
  70. Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
    João Pedro Ferrari‐Souza, Pâmela C.L. Ferreira, Bruna Bellaver, Cécile Tissot, Yi-Ting Wang, Douglas Teixeira Leffa, Wagner Scheeren Brum, Andréa Lessa Benedet, Nicholas James Ashton, Marco Antônio De Bastiani et al. · 2022 · medRxiv
  71. Inhibition of BET proteins modulates amyloid-beta accumulation and cognitive performance in middle-aged mice prenatally exposed to maternal immune activation
    Marta Matuszewska, Anna Wilkaniec, Magdalena Gąssowska-Dobrowolska, Magdalena Cieślik, Gabriela Olech-Kochańczyk, Ewelina Pałasz, Elżbieta Gawinek, Marcin Strawski, Grzegorz Arkadiusz Czapski · 2025 · Frontiers in Molecular Neuroscience
  72. Neuron–Glia Crosstalk in the Regulation of Astrocytic Antioxidative Mechanisms Following CNS Injury
    Piotr K. Zakrzewski, Tomasz Boczek · 2025 · Antioxidants
  73. Plasma GFAP as a mediator and moderator of Aβ, tau, and neurodegeneration in Alzheimer’s disease
    Jun Sung Kim, Dahyun Yi, Min Soo Byun, Hyejin Ahn, Gijung Jung, HyeJi Choi, Jun‐Young Lee, Koung Mi Kang, Sohn Chul-Ho, Yun-Sang Lee et al. · 2026 · npj Dementia
  74. Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States
    Madison K. Kuhn, Elizabeth A. Proctor · 2024 · Proteins Structure Function and Bioinformatics
  75. Multimodal Imaging Markers of Cognitive Resilience and Molecular Mechanisms of Brain Resilience in Alzheimer’s Disease
    Ze Xiao Yang, Jinhua Sheng, Qiao Zhang, Xiaoying Zhao, Yan Song, Guiguan Dong, Rong Zhang, Hongliang Zhao, Jialei Wang, Rong Pan et al. · 2025 · Journal of Integrative Neuroscience
  76. The neuroinflammatory role of microRNAs in Alzheimer’s disease: pathological insights to therapeutic potential
    Wenjia Liu, Xin Rao, Wen Sun, Xiaodong Chen, Liyang Yu, Jiangtao Zhang, Jiong Chen, Xiaorong Zheng · 2024 · Molecular and Cellular Biochemistry
  77. A Model of Systemic Inflammation to Study Neuroinflammation
    Vincenzo Sorrenti, Pietro Giusti, Morena Zusso · 2017 · Methods in molecular biology
  78. PET Applications in Animal Models of Neurodegenerative and Neuroinflammatory Disorders
    Makoto Higuchi, Jun Maeda, Bin Ji, Masaki Tokunaga, Ming‐Rong Zhang, Masahiro Maruyama, Maiko Ono, Toshimitsu Fukumura, Tetsuya Suhara · 2011 · Current topics in behavioral neurosciences
  79. Where do white matter alterations dovetail with the cascade model of Alzheimer’s disease?
    Heidi I.L. Jacobs, Rachel F. Buckley · 2018 · Brain
  80. Plasma GFAP outperforms CSF GFAP in detecting amyloid pathology and is associated with increased risk of clinical progression in early Alzheimer’s disease
    Arda Can Cetindag, Carola G. Schipke, Hermann Esselmann, Niels Kruse, Jens Wiltfang, Anja Schneider, Klaus Fließbach, Carolin Miklitz, Franziska Maier, Katharina Büerger et al. · 2026 · The Journal of Prevention of Alzheimer s Disease
  81. Integrated Bioinformatics and Machine Learning Algorithms Analyses Highlight Related Pathways and Genes Associated with Alzheimer's Disease
    Hui Zhang, Qidong Liu, Xiaoru Sun, Yaru Xu, Yiling Fang, Silu Cao, Bing Niu, Cheng Li · 2021 · Current Bioinformatics
  82. A kinetic scheme to examine the role of glial cells in the pathogenesis of Alzheimer’s disease
    Ranjit Arulnayagam Thuraisingham · 2022 · Metabolic Brain Disease
  83. Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies
    2022
  84. Relationship between reactive astrocytes, by [ 18 F]SMBT-1 imaging, with amyloid-beta, tau, glucose metabolism, and microgliosis in mouse models of Alzheimer’s disease
    Yanyan Kong, Cinzia Maschio, Xuefeng Shi, Bolin Yao, Fang Xie, Chuantao Zuo, Uwe Konietzko, Kuangyu Shi, Axel Rominger, Jianfei Xiao et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Hippocampal Reduction of α-Synuclein via RNA Interference Improves Neuropathology in Alzheimer’s Disease Mice
    Andre Direito Goulart Leitao, Brian J. Spencer, Floyd M. Sarsoza, Jennifer Ngolab, Jessica Amalraj, Eliezer Masliah, Chengbiao Wu, Robert A. Rissman · 2023 · Journal of Alzheimer s Disease
  86. Fueling Alzheimer’s Disease: Where Does Immunometabolism Stand?
    Sónia C. Correia, George L. Perry, Paula Isabel Moreira · 2024 · Journal of Alzheimer s Disease
  87. Assessing the Relationship of Brain Metabolites to Cortical Thickness and Dementia Symptoms in Adults with Down Syndrome: A Pilot Study
    Katherine A. Koenig, Pallab K. Bhattacharyya · 2024 · Brain Sciences
  88. DDT exposure induces microglial activation and disease-associated microglial signatures: Relevance to mechanisms of Alzheimer’s disease
    Isha Mhatre‐Winters, Aseel Eid, Nicole Blum, Yoonhee Han, Ferass M. Sammoura, Long‐Jun Wu, Jason Richardson · 2025 · NeuroToxicology
  89. Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer’s disease brain are associated with Aβ, tau pathologies and synaptic loss
    Cinzia Maschio, Óscar Moreno, Junlong Wang, Upasana Maheshwari, Annika Keller, Uwe Konietzko, Daniel Razansky, Agneta K. Nordberg, Axel Rominger, Christoph Höck et al. · 2025 · Alzheimer s Research & Therapy
  90. Microarray Analysis Revealed Inflammatory Transcriptomic Changes after LSL60101 Treatment in 5XFAD Mice Model
    Foteini Vasilopoulou, Carmen Escolano, Mercè Pallàs, Christian Griñán‐Ferré · 2021 · Genes
  91. EFFECT OF DATE FRUIT (PHOENIX DACTYLIFERA L.) EXTRACT ON TNFα LEVELS AND BRAIN WEIGHT OF ALZHEIMER’S MODEL RATS
    Elita Marintan, Brian Wasita, Adi Magna · 2022 · MNJ (Malang Neurology Journal)
  92. Applications of Induced Pluripotent Stem Cell-Derived Glia in Brain Disease Research and Treatment
    Zhiqi Yang, Mingyue Gong, Chuanyan Yang, Chunhai Chen, Kuan Zhang · 2023 · Handbook of experimental pharmacology
  93. Neuropathologic evaluation of cerebrovascular disease in patients with rheumatoid arthritis
    Rachel A. Larsen, Eleni Constantopoulos, Chanakya Kodishala, Edward Lovering, Rakesh Kumar, Cassondra A. Hulshizer, Ryan J. Lennon, Cynthia S. Crowson, Aivi T. Nguyen, Elena Myasoedova · 2023 · Rheumatology
  94. Alzheimer’s disease brain-derived tau extracts show differential processing and transcriptional effects in human astrocytes
    Matthew J. Reid, M. L. Salazar, C. Troakes, Steven Lynham, Deepak P. Srivastava, B. Perez-Nievas, Wendy Noble · 2025 · iScience
  95. Alzheimer's Disease Biomarker-Nigeria (ADIBIO-N): Cohort description and baseline data report
    Valentine A. Ucheagwu, D. Morgan, Savanah Rose, Chiamaka Odilora, C. Okafor, Bruno J. Giordani · 2025 · Journal of Alzheimer's Disease
  96. Decoding the mechanisms of amyloid-β in synaptic toxicity
    Piotr Toruński, Giusy Pizzirusso, Bengt G. Winblad, Luis Enrique Arroyo‐García · 2026 · Journal of Alzheimer s Disease
  97. How does type 2 diabetes modify the risk of Alzheimer's disease?
    Greg Trevor Sutherland, A. Chen, H‐T. Nguyen‐Hao, Hamish D. Mundell, E. Aladyeva, Markus J Hofer, Oscar Harari, S. M. Twigg · 2026 · Alzheimer s & Dementia
  98. Neuroinflammation in Alzheimer’s Disease (AD) and Glioblastoma (GBM): Shared Mechanisms and Therapeutic Insights
    Karolina Mikołajczak, James Chmiel, Jerzy Leszek · 2026 · Cells
  99. Neuroinflammation and Oxidative Stress in Models of Parkinson’s Disease and Protein-Misfolding Disorders
    Ronald B. Tjalkens, Karin M. Streifel, Julie A. Moreno · 2017 · Royal Society of Chemistry eBooks
  100. Neuroprotective Profile of Triazole Grandisin Analogue against Amyloid-Beta Oligomer-Induced Cognitive Impairment
    Victor H. B. de Andrade, Erick Yudi Maruyama Rodrigues, Nayara A. F. Dias, Gabriela F. C. Ferreira, Diego B. Carvalho, Amarith R. das Neves, Paola Mayara Valente Coronel, Murilo K. A. Yonekawa, Eduardo Benedetti Parisotto, Edson dos Anjos dos Santos et al. · 2023 · ACS Chemical Neuroscience